A groundbreaking trial found that Iberdomide, a cereblon modulator, can be added as a background medication in subacute and ...

In a phase 2 trial, iberdomide was associated with improved symptoms when added to standard lupus medications in patients with subacute and chronic cutaneous lupus erythematosus ...

Extra-cutaneous symptoms that suggest systemic ... A biopsy of this pustular lesion is slightly atypical of lupus; however, it may represent an acute inflammatory component rather than a classic ...

The investigators observed these cells in the bone marrow of individuals with acute disseminated lupus ... therapy for almost all individuals with lupus. Antimalarials, used in the past principally ...

Some subtypes of cutaneous lupus are acute, subacute, and chronic cutaneous lupus. Other skin problems that lupus patients can develop are ulcers or sores, Raynaud’s phenomenon, livedo ...

With lupus, the attack is systemic (affecting multiple organ systems are affected), while scleroderma primarily affects the ...

Lupus enteritis was the most common cause of acute abdominal pain. Patients were divided into ... p=0.59), central nervous system (0/17, 4/21, 19/137, p=0.19), skin/mucosa (10/17, 16/21, 92/137, ...

It is also planning a late-stage study in lupus nephritis in a bid to match Benlysta, as well as trials in cutaneous lupus erythematosus and myositis. Merck KGaA is shaping up to take on Daiichi ...

Arthritis is a common acute or chronic condition affecting the joints and surrounding tissues. It’s estimated that roughly 18 ...

But those kinds of risk factors aren’t enough on their own. People have to be exposed to one or more “triggers” that tip the ...